William G. Wierda, M.D., Ph.D.


Combining and Sequencing Agents in CLL

January 30, 2018

William G. Wierda, M.D., Ph.D., medical director of the Leukemia Center at The University of Texas MD Anderson Cancer Center, discusses how to best combine and sequence therapies for patients with chronic lymphocytic leukemia (CLL).